Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Multiple Myeloma 5Neoplasms 3Glioma 2Unspecified Childhood Solid Tumor, Protocol Specific 1Rhabdoid Tumor 1Ovarian Neoplasms 1Oligodendroglioma 1Neuroectodermal Tumors, Primitive 1Medulloblastoma 1Glioblastoma 1Fallopian Tube Neoplasms 1Diffuse Intrinsic Pontine Glioma 1Breast Neoplasms 1Brain Neoplasms 1Astrocytoma 1Anemia 1

Interventions

Cyclophosphamide 6Filgrastim 5Etoposide 5fludarabine 4Temozolomide 4Granulocyte Colony-Stimulating Factor 4Carboplatin 4Thiotepa 3Stem Cell Transplantation 3Peripheral Blood Stem Cell Transplantation 3Melphalan 3Automobiles 3tazemetostat 2sargramostim 2ribociclib 2fludarabine phosphate 2Vorinostat 2Vincristine 2Topotecan 2Sirolimus 2Mesna 2Busulfan 2veliparib 1trametinib 1thymoglobulin 1sonidegib 1selinexor 1reolysin 1pembrolizumab 1pegylated granulocyte colony-stimulating factor 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Rhabdoid Tumor × reolysin × Clear all
NCT02444546 2023-04-24

Wild-Type Reovirus in Combination With Sargramostim in Treating Younger Patients With High-Grade Relapsed or Refractory Brain Tumors

Mayo Clinic

Phase 1 Completed
6 enrolled
CNS

Diffuse Intrinsic Pontine Glioma, Astrocytoma, Brain Neoplasms, Glioma, Medulloblastoma, Oligodendroglioma, Neuroectodermal Tumors, Primitive, Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡